Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05574361 · ClinicalTrials.gov registry record · NA
Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA)
A NA study of Liver Transplantation, sponsored by Organ Recovery Systems.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 5
- Study locations
NCT05574361: Active NA study of Liver Transplantation, sponsored by Organ Recovery Systems.
NCT05574361 is a NA study of Liver Transplantation that is active but no longer recruiting, run by Organ Recovery Systems. The registered enrollment target is 120 participants, below the 313-participant average among 12 other Liver Transplantation trials with a reported enrollment target (62% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05574361, a NA study of Liver Transplantation, is active but no longer recruiting, sponsored by Organ Recovery Systems.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 5
- Study locations
Study Summary
To provide continued access for the LLT system to provide additional safety data in support of the PILOT pivotal efficacy and safety trial
Primary Outcome
EAD defined as total bilirubin ≥ 10 mg/dL or International Normalized Ratio (INR) ≥ 1.6 or Aspartate Aminotransferase (AST) \>2000IU/L or Alanine Aminotransferase (ALT) \> 2000 IU/L
Conditions Studied
Interventions
- DEVICE Hypothermic Machine Perfusion
Study Locations (5)
Illinois
- Northwestern Memorial Hospital - Chicago
- University of Chicago Medical Center - Chicago
New Jersey
- Rutgers New Jersey Medical School - Newark
Ohio
- University of Cincinnati Medical Center - Cincinnati
Utah
- Intermountain Medical Center - Murray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-09-19 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
What the registry record for NCT05574361 still lists
NCT05574361 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 313-participant average among 12 other Liver Transplantation trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Liver Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Hypothermic Machine Perfusion is the first listed.
NCT05574361 lists 5 locations in 4 states (Illinois, New Jersey, Ohio).
Frequently Asked Questions
What is clinical trial NCT05574361 about?
NCT05574361 is a clinical study titled "Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA)". To provide continued access for the LLT system to provide additional safety data in support of the PILOT pivotal efficacy and safety trial
What is the current status of trial NCT05574361?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-09-19. Estimated completion is 2027-02-28.
What conditions does trial NCT05574361 study?
This clinical trial studies the following conditions: Liver Transplantation.
What interventions are being tested in trial NCT05574361?
The interventions under investigation include: Hypothermic Machine Perfusion (DEVICE).
Who is sponsoring clinical trial NCT05574361?
This trial is sponsored by Organ Recovery Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05574361 being conducted?
This trial has 5 study locations across Illinois, New Jersey, Ohio, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05574361's enrollment target sits among peer trials
120 7th of 12 higher than 6 of 12 other Liver Transplantation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Transplantation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mediterranean Diet Post-liver Transplantation
RECRUITING · NA
-
Sequential Hypo- and Normo-thermic Perfusion to Preserve Extended Criteria Donor Livers for Transplantation
ACTIVE NOT RECRUITING · NA
-
Study of Resistance Strengthening Versus Ambulation Post-Liver Transplant
COMPLETED · NA
-
HOPE Against Cancer Recurrence in HCC
RECRUITING · Phase 4
-
Reducing Pain With Methadone and Ketamine in Liver Transplant
RECRUITING · Phase 4
-
Immune Tolerance Induction After Liver Transplantation
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI